Oraphan Siriprakaisil
Overview
Explore the profile of Oraphan Siriprakaisil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
134
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sullivan B, Craig C, Bender A, Blake E, Siriprakaisil O, Sukrakanchana P, et al.
J Antimicrob Chemother
. 2025 Feb;
PMID: 39995274
Background: Tenofovir diphosphate concentration in red blood cells is an objective measure of long-term oral pre-exposure prophylaxis (PrEP) or antiretroviral therapy (ART) adherence. However, current methods for measuring tenofovir diphosphate...
2.
Niu X, Kubiak R, Siriprakaisil O, Klinbuyaem V, Sukrakanchana P, Cressey R, et al.
Open Forum Infect Dis
. 2022 Aug;
9(8):ofac405.
PMID: 36004315
Background: Tenofovir-diphosphate (TFV-DP) measured in dried blood spots (DBS) and tenofovir (TFV) measured in urine/plasma have been used to measure TFV-based oral pre-exposure prophylaxis (PrEP) adherence. However, there are limited...
3.
Cressey T, Siriprakaisil O, Kubiak R, Klinbuayaem V, Sukrakanchana P, Quame-Amaglo J, et al.
Int J Infect Dis
. 2020 Jun;
97:365-370.
PMID: 32553717
Objectives: The aim was to fully characterize the plasma and urine washout pharmacokinetics of tenofovir (TFV) in adults following 6 weeks of controlled levels of tenofovir disoproxil fumarate (TDF) adherence,...
4.
Gandhi M, Wang G, King R, Rodrigues W, Vincent M, Glidden D, et al.
AIDS
. 2019 Oct;
34(2):255-260.
PMID: 31634188
Objective: HIV prevention and treatment studies demonstrate that pharmacologic adherence metrics are more accurate than self-report. Currently available metrics use liquid-chromatography/tandem-mass-spectrometry (LC-MS/MS), which is expensive and laboratory-based. We developed a...
5.
Drain P, Kubiak R, Siriprakaisil O, Klinbuayaem V, Quame-Amaglo J, Sukrakanchana P, et al.
Clin Infect Dis
. 2019 Jul;
70(10):2143-2151.
PMID: 31314073
Background: Direct measurement of tenofovir (TFV) in urine could be an objective measure to monitor adherence to preexposure prophylaxis (PrEP) or TFV-based antiretroviral therapy (ART). Methods: We conducted a 3-arm...
6.
Gandhi M, Bacchetti P, Spinelli M, Okochi H, Baeten J, Siriprakaisil O, et al.
J Acquir Immune Defic Syndr
. 2019 Jan;
81(1):72-77.
PMID: 30664078
Background: Current pharmacologic adherence monitoring for antiretrovirals involves expensive, labor-intensive liquid chromatography/tandem mass spectrometry (LC-MS/MS)-based methods. Antibody-based assays can monitor and support adherence in real time. We developed a tenofovir...
7.
Cressey T, Siriprakaisil O, Klinbuayaem V, Quame-Amaglo J, Kubiak R, Sukrakanchana P, et al.
BMC Infect Dis
. 2017 Jul;
17(1):496.
PMID: 28705153
Background: Tenofovir disoproxil fumarate (TDF) is key component of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) for HIV, but existing tools to monitor drug adherence are often inaccurate. Detection of...